Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

C-19

C-19 Increase the proportion of men who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider

Baseline: 14.4 percent of men aged 40 years and over had discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider in 2010 (age adjusted to the year 2000 standard population)
Target: 15.9 percent
Target-Setting Method: Minimal statistical significance
Data Sources:
National Health Interview Survey (NHIS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Revision History:
This objective was revised. Read more about the revision history.